Citi upgraded Arkema (ARKAY) to Buy from Neutral with a price target of EUR 100, up from EUR 93.50, in a sector note on European Diversified Chemicals. The firm believes the sector is “under-earning, under-owned, and trade on cheap valuations, which limits the downside, but added that its “Deep Dive risk/reward-assessment shows Arkema as best positioned for 2025.” Additionally, Citi opened a pair trade Overweight Arkema vs. Underweight Syensqo.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter